BST2 Antibody (SBI Biotech patent anti-BST2) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28007H
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
HRP
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # SBI Biotech patent anti-BST2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for BST2 Antibody (SBI Biotech patent anti-BST2) [HRP]
Immunogen
BST2 / CD317
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for BST2 Antibody (SBI Biotech patent anti-BST2) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: BST-2/Tetherin
Long Name
Bone Marrow Stromal Cell Antigen 2
Alternate Names
BST2, CD317, HM1.24 Antigen, NPC-A-7, Tetherin
Gene Symbol
BST2
Additional BST-2/Tetherin Products
Product Documents for BST2 Antibody (SBI Biotech patent anti-BST2) [HRP]
Product Specific Notices for BST2 Antibody (SBI Biotech patent anti-BST2) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...